Semaglutide is an injectable drug sold under the brand names Ozempic and Wegovy. Doctors describe it as a game-changing drug for people looking to manage diabetes and obesity, but it comes with some risks.
Eating disorder survivors and experts join a discussion about the recent decision to end the University of Iowa Hospitals and Clinics eating disorder inpatient program.